CLGN Award Disclosure
Rotem Eran · SEC Form 4 · Filed Sep 8, 2026
Award
Calculated transaction value
$0
Rotem Eran Deputy CEO And CFO
Transaction date
Sep 3, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed 5 days later
CLGN daily price context
Close on/before transaction
$3.41
Sep 3, 2026
Close before public filing
$3.33
Sep 7, 2026
Return since public filing
+6.48%
Through Sep 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 510,372 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001213900-26-098038
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Collplant Biotechnologies Ltd CLGN Current | Award | Sep 3, 2026 | $0 |